NCT04414878 - VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial | Biotech Hunter

Enrollment

145

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2027

Conditions

Aortic Stenosis

Interventions

DEVICE

VitaFlow™ II Transcatheter Aortic Valve System

VitaFlow™ II Transcatheter Aortic Valve System contains a valve stent-VitaFlow™ Aortic Valve, a delivery system-VitaFlow™ Delivery System, loading tools, and a guide-wire

Trial Locations (4)

Unknown

RECRUITING

Fuwai Hospital, Beijing

RECRUITING

Zhongshan Hospital, Shanghai

RECRUITING

West China Hospital of Sichuan University, Chengdu

RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

Shanghai MicroPort CardioFlow Medtech Co., Ltd.

INDUSTRY